Risperidone ISM as a New Option in the Clinical Management of Schizophrenia: A Narrative Review.

Saved in:
Bibliographic Details
Title: Risperidone ISM as a New Option in the Clinical Management of Schizophrenia: A Narrative Review.
Authors: Álamo C; Department of Biomedical Sciences, Alcalá University. Alcalá de Henares. , C/ Serrano Galvache 42, 9ºC , 28033, Madrid, Spain. cecilio.alamo@uah.es.
Source: Advances in therapy [Adv Ther] 2022 Nov; Vol. 39 (11), pp. 4875-4891. Date of Electronic Publication: 2022 Sep 01.
Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36048404
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Risperidone ISM as a New Option in the Clinical Management of Schizophrenia: A Narrative Review.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Álamo+C%22">Álamo C</searchLink>; Department of Biomedical Sciences, Alcalá University. Alcalá de Henares. , C/ Serrano Galvache 42, 9ºC , 28033, Madrid, Spain. cecilio.alamo@uah.es.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228611864%22">Advances in therapy</searchLink> [Adv Ther] 2022 Nov; Vol. 39 (11), pp. 4875-4891. <i>Date of Electronic Publication: </i>2022 Sep 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Health+Communications+Inc%22">Health Communications Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8611864 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1865-8652 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220741238X%22">0741238X </searchLink><i>NLM ISO Abbreviation: </i>Adv Ther
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36048404
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s12325-022-02299-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 4875
    Titles:
      – TitleFull: Risperidone ISM as a New Option in the Clinical Management of Schizophrenia: A Narrative Review.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Álamo C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2022 Nov
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1865-8652
          Numbering:
            – Type: volume
              Value: 39
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Advances in therapy
              Type: main
ResultId 1